153 related articles for article (PubMed ID: 6453176)
1. [Clinical and histological studies of endometrial carcinoma of the uterus treated with medroxy-progesterone-acetate (author's transl)].
Ohta M; Takeda A; Ninagawa T; Tomoda Y
Nihon Gan Chiryo Gakkai Shi; 1980 Dec; 15(7):1098-103. PubMed ID: 6453176
[No Abstract] [Full Text] [Related]
2. [Progesterone receptors in endometrial carcinoma and their response to medroxyprogesterone acetate].
Feng YJ; Zhang XY
Zhonghua Fu Chan Ke Za Zhi; 1989 May; 24(3):153-5, 189. PubMed ID: 2530067
[TBL] [Abstract][Full Text] [Related]
3. [Adjuvant hormone therapy in endometrial carcinoma: medroxyprogesterone acetate versus tamoxifen-medroxyprogesterone acetate sequential therapy].
Vavra N; Salzer H; Sevelda P; Breitenecker G; Czerwenka K; Kucera H
Gynakol Rundsch; 1990; 30(3):133-43. PubMed ID: 2147161
[TBL] [Abstract][Full Text] [Related]
4. [Adjuvant gestagen therapy in stage I endometrial cancer].
Lahousen M; Pickel H
Zentralbl Gynakol; 1988; 110(16):1013-7. PubMed ID: 2973195
[TBL] [Abstract][Full Text] [Related]
5. [Response of estrogen and progesterone receptors to treatment with large doses of progestogen (depo-provera) in endometrial cancer].
Thurzó L
Zentralbl Gynakol; 1990; 112(17):1111-5. PubMed ID: 2148245
[TBL] [Abstract][Full Text] [Related]
6. [Progestins in combined treatment of endometrial cancer].
Voznyĭ EK; Titova VA
Sov Med; 1990; (9):102-7. PubMed ID: 2148437
[No Abstract] [Full Text] [Related]
7. [Combination with medroxyprogesterone acetate and chemotherapy making possible complete removal of uterine corpus carcinoma].
Tajima H; Okada T; Fujimori Y; Tomioka Y; Hirano M; Yoshida T; Ikeda S; Hata T
Gan To Kagaku Ryoho; 1989 Jul; 16(7):2461-4. PubMed ID: 2526620
[TBL] [Abstract][Full Text] [Related]
8. [Flow cytometric study on the action of progestogen in patients with adenocarcinoma and precancerous lesions of the endometrium].
Nishiya I; Izutsu T; Satoh K; Yoshizumi N; Kurokawa Y; Kagabu T
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jul; 37(7):1161-8. PubMed ID: 3161958
[TBL] [Abstract][Full Text] [Related]
9. [Effect of long-term high-dose progesterone (Depo-Provera) therapy on endometrial carcinoma].
Szarvas Z; Zsolnai B; Gimes G; Hidvégi J
Morphol Igazsagugyi Orv Sz; 1985 Oct; 25(4):253-60. PubMed ID: 2933583
[No Abstract] [Full Text] [Related]
10. Evaluation of in vivo and in vitro responses of endometrial adenocarcinoma to progestins.
Holinka CF; Deligdisch L; Deppe G; Fleming H; Namit C; de la Pena MM; Gurpide E
Adv Exp Med Biol; 1981; 138():365-76. PubMed ID: 6211063
[No Abstract] [Full Text] [Related]
11. [Clinovir treatment of adenocarcinoma of the uterus with lung metastases].
Stertmann WA; Hocke M; Röttger P
MMW Munch Med Wochenschr; 1983 Jul; 125(29-30):685-6. PubMed ID: 6225946
[No Abstract] [Full Text] [Related]
12. [Estrogen and progesterone receptors in endometrial carcinoma during high-dose progestogen (Depo-Provera) therapy].
Thurzó L; Sas M; Falkay G
Orv Hetil; 1986 Oct; 127(43):2613-6. PubMed ID: 2947029
[No Abstract] [Full Text] [Related]
13. Treatment of recurrent or metastatic poorly differentiated adenocarcinoma of the endometrium with tamoxifen and medroxyprogesterone acetate.
Kline RC; Freedman RS; Jones LA; Atkinson EN
Cancer Treat Rep; 1987 Mar; 71(3):327-8. PubMed ID: 2949831
[No Abstract] [Full Text] [Related]
14. [Cell surface changes after high-dosage progesterone treatment in endometrial carcinoma].
Szarvas Z; Zsolnai B
Zentralbl Gynakol; 1984; 106(14):1010-7. PubMed ID: 6239468
[TBL] [Abstract][Full Text] [Related]
15. [Effect of treatment with oral 6-methyl-17-hydroxyprogesterone acetate in endometrial adenocarcinoma. Histochemical and ultrastructural aspects].
Vecchietti G; Gerzeli G; Zanoio L; Novelli GG; Barni S; Patton R
Minerva Ginecol; 1981 Apr; 33(4):293-306. PubMed ID: 7243070
[No Abstract] [Full Text] [Related]
16. Persistence of endometrial activity after radiation therapy for cervical carcinoma.
Barnhill D; Heller P; Dames J; Hoskins W; Gallup D; Park R
Obstet Gynecol; 1985 Dec; 66(6):805-8. PubMed ID: 2999661
[TBL] [Abstract][Full Text] [Related]
17. [Histomorphological investigations of endometrial carcinoma during progestional treatment with chlormadione acetate (author's transl)].
Boquoi E; Kreuzer G
Geburtshilfe Frauenheilkd; 1973 Sep; 33(9):697-708. PubMed ID: 4129072
[No Abstract] [Full Text] [Related]
18. Endometrial carcinoma: steroid receptors and response to medroxyprogesterone acetate.
Quinn MA; Cauchi M; Fortune D
Gynecol Oncol; 1985 Jul; 21(3):314-9. PubMed ID: 3159630
[TBL] [Abstract][Full Text] [Related]
19. [Therapy of advanced endometrial cancer].
Okada H; Yamamoto T
Gan To Kagaku Ryoho; 1990 Sep; 17(9):1848-55. PubMed ID: 2144105
[TBL] [Abstract][Full Text] [Related]
20. Tamoxifen and medroxyprogesterone therapy for advanced endometrial carcinoma.
Rendina GM; Donadio C; Fabri M; Mazzoni P; Nazzicone P
Eur J Obstet Gynecol Reprod Biol; 1984 Jun; 17(4):285-91. PubMed ID: 6235140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
